Montag & Associates’s Ambev ABEV Stock Holding History

Montag & Associates’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14K	Hold	4,808	–	–	﹤0.01%	708
2025 Q4	$12.3K	Hold	4,808	–	–	﹤0.01%	754
2025 Q3	$10.8K	Hold	4,808	–	–	﹤0.01%	750
2025 Q2	$11.7K	Sell	4,808 -404	-8%	-$983	﹤0.01%	733
2025 Q1	$12.3K	Buy	5,212 +629	+14%	+$1.26K	﹤0.01%	768
2024 Q4	$8.95K	Hold	4,583	–	–	﹤0.01%	797
2024 Q3	$11.2K	Buy	4,583 +419	+10%	+$940	﹤0.01%	799
2024 Q2	$8.54K	Buy	4,164 +1,162	+39%	+$2.65K	﹤0.01%	784
2024 Q1	$7.45K	Buy	3,002 +662	+28%	+$1.72K	﹤0.01%	783
2023 Q4	$6.85K	Hold	2,340	–	–	﹤0.01%	802
2023 Q3	$6.04K	Hold	2,340	–	–	﹤0.01%	791
2023 Q2	$7.44K	Buy	2,340 +295	+14%	+$868	﹤0.01%	787
2023 Q1	$5.77K	Buy	2,045 +633	+45%	+$1.66K	﹤0.01%	805
2022 Q4	$4.01K	Buy	+1,412	New	+$4.11K	﹤0.01%	836

Other funds holding ABEV

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $436M AUM 42.05% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Montag & Associates's ABEV Position: Q1 2026 in Review

Montag & Associates held its Ambev (ABEV) position steady in Q1 2026 at 4,808 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Montag & Associates first reported a position in ABEV in Q4 2022 and has held it in 14 quarters since. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

Montag & Associates held 4,808 shares of Ambev worth $14K as of Q1 2026.
Montag & Associates left its Ambev share count unchanged in Q1 2026.
Ambev made up ﹤0.01% of Montag & Associates's portfolio in Q1 2026, its #708 holding.
Montag & Associates first reported a position in Ambev in Q4 2022 and has held it in 14 quarters since.
402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.